优莎娜健康科学公司近日披露了2025年第四季度及全年财务数据，同时向市场传递了2026财年的业绩预期。最新财报显示，这家营养补充剂巨头在复杂经济环境中仍保持战略定力，其全球业务布局与产品创新成为支撑增长的关键支点。
尽管面临通胀压力与汇率波动挑战，公司通过优化供应链与精准营销实现了成本管控。管理层在展望中强调，将加速数字化渠道转型，并针对亚太市场推出本地化健康解决方案。新财年的增长路径将聚焦高潜力细分领域，通过科技赋能提升客户粘性。
分析师指出，优莎娜的业绩指引反映出对新兴市场消费升级趋势的精准把握。其旗舰产品线的技术迭代与可持续发展战略的深度融合，或将为股东创造长期价值。未来季度业绩能否突破预期，取决于新品市场渗透率与跨境电商渠道的协同效应。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.